12-110911079-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_000432.4(MYL2):c.499T>G(p.Ter167Gluext*?) variant causes a stop lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000432.4 stop_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYL2 | NM_000432.4 | c.499T>G | p.Ter167Gluext*? | stop_lost | Exon 7 of 7 | ENST00000228841.15 | NP_000423.2 | |
MYL2 | NM_001406745.1 | c.457T>G | p.Ter153Gluext*? | stop_lost | Exon 6 of 6 | NP_001393674.1 | ||
MYL2 | NM_001406916.1 | c.442T>G | p.Ter148Gluext*? | stop_lost | Exon 7 of 7 | NP_001393845.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYL2 | ENST00000228841.15 | c.499T>G | p.Ter167Gluext*? | stop_lost | Exon 7 of 7 | 1 | NM_000432.4 | ENSP00000228841.8 | ||
MYL2 | ENST00000548438.1 | c.457T>G | p.Ter153Gluext*? | stop_lost | Exon 6 of 6 | 3 | ENSP00000447154.1 | |||
MYL2 | ENST00000663220.1 | c.442T>G | p.Ter148Gluext*? | stop_lost | Exon 7 of 7 | ENSP00000499568.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy 10 Uncertain:1
This sequence change disrupts the translational stop signal of the MYL2 mRNA. It is expected to extend the length of the MYL2 protein, but the length of the extension is unknown as no new stop signal is encountered. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with MYL2-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at